Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Neutrophil-to-lymphocyte Ratio (NLR) and Platelet-to-lymphocyte Ratio (PLR) Levels Following IPACK Block in Knee Arthroplasty: a Randomized, Controlled Trial.

NCT06304298 is registered in ClinicalTrials.gov with Poznan University of Medical Sciences as lead sponsor.

NCT NCT06304298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06304298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Neutrophil-to-lymphocyte Ratio (NLR) and Platelet-to-lymphocyte Ratio (PLR) Levels Following IPACK Block in Knee Arthroplasty: a Randomized, Controlled Trial.
Lead sponsor
Poznan University of Medical Sciences
Phase
Phase 4
Overall status
Completed
Start date
March 30, 2024
Completion date
February 10, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

knee arthropathy, knee osteoarthritis, knee pain chronic